GCANRx Announces Relisting To OTCQB Market Tier

Core Viewpoint - The Greater Cannabis Company, Inc. has received approval for its common stock to be quoted on the OTCQB Venture Market, which is expected to enhance investor benefits through improved reporting standards and greater market visibility [1]. Group 1: Company Overview - The Greater Cannabis Company is a clinical stage biopharmaceutical company focused on developing cannabinoid therapeutics, particularly for neuropsychiatric disorders [4]. - The company's mission is to bring innovative cannabis-based treatments to the global market to address unmet medical needs [4]. Group 2: Market Position and Compliance - The move to the OTCQB requires companies to meet high financial standards and comply with U.S. securities laws, which enhances transparency and reporting standards [1]. - The OTCQB is recognized by the SEC as an established public market, which can lead to increased liquidity and awareness for companies listed on it [1].